Skip to content

K-Dense-AI/scientific-agent-skills / skills/clinical-decision-support

clinical-decision-support

Verified

Prepares and validates research-only clinical decision-support evaluation, evidence-profile, cohort, survival, biomarker/model, privacy, and governance artifacts. Supports aggregate or synthetic research documentation and traceability, excluding patient care and live clinical operation.

references/cohort_evaluation.md

View on GitHub
# Aggregate Cohort Evaluation

## Scope

This workflow documents cohorts using pre-aggregated counts and summaries. It does not ingest records, classify people, estimate a patient-specific risk, or recommend care.

## Protocol Before Results

Pre-specify:

- objective and target population;
- study design and setting;
- index date/time zero;
- eligibility and sampling;
- exposure, comparator, outcomes, covariates, and time windows;
- causal estimand if making a causal claim;
- confounding strategy;
- missing-data strategy;
- subgroup and interaction analyses;
- multiplicity control;
- sensitivity and negative-control analyses;
- disclosure policy.

For routinely collected data, document code sets, phenotypes, database versions, linkage quality, data provenance, and validation.

## Participant Flow

Report aggregate counts for:

1. source population;
2. eligibility assessed;
3. excluded by reason;
4. included;
5. analysis populations;
6. missing outcome or follow-up;
7. subgroup availability.

Apply suppression before releasing the flow. Do not reconstruct suppressed values through totals.

## Table 1

Use summaries appropriate to distributions and measurement:

- categorical: count, denominator, percentage, missing;
- continuous: mean and standard deviation or median and quartiles;
- time-dependent or repeated measures: define the summary window;
- assay measurements: units, platform, detection limits, batch, and transformation.

Baseline significance tests do not measure meaningful imbalance and are not generated by the bundled table helper. If comparison is needed, pre-specify descriptive standardized differences or another justified measure and interpret it in context.

## Effect Estimation

Match measure to question:

- prevalence/risk: risk difference and risk ratio;
- rates: rate difference and rate ratio;
- odds: odds ratio, with care when outcomes are common;
- time to event: estimand-aligned survival measures;
- repeated outcomes: model and covariance assumptions;
- diagnostic accuracy: sensitivity/specificity and predictive values at prespecified thresholds.

Report absolute and relative effects with uncertainty when both are relevant. A p-value is not an effect size and “not significant” is not evidence of no difference.

## Confounding and Bias

Address:

- confounding by indication;
- selection and collider bias;
- immortal-time and time-varying treatment bias;
- informative observation/censoring;
- measurement error and misclassification;
- missing data;
- outcome ascertainment;
- site and calendar-time effects;
- data-driven subgroup or cut-point selection;
- unmeasured confounding.

State which variables were selected before analysis and why. Do not select confounders solely by univariable p-values. Distinguish prediction from causal inference.

## Subgroups and Fairness

Subgroup work must document:

- rationale and prespecification;
- representation and missingness;
- sample sizes and event counts;
- effect estimates with intervals;
- interaction tests when effect heterogeneity is the question;
- multiplicity;
- measurement validity across groups;
- intersectional and site effects where feasible;
- whether categories are self-reported, assigned, or derived;
- risk of reinforcing structural inequities.

Do not rank groups or declare fairness from one metric. Small groups may require pooling, secure analysis, or non-release rather than unstable public estimates.

## Biomarker Cohorts

Record:

- biomarker category using FDA-NIH BEST terminology;
- biological and analytical rationale;
- specimen collection and handling;
- assay platform, version, units, and quality controls;
- prespecified threshold and source;
- analytical validation;
- blinding to outcomes;
- missing/failed assays;
- internal and external validation;
- distinction among prognostic, predictive, and treatment-effect interaction claims.

Never derive a threshold on the evaluation cohort and present it as validated without independent confirmation.

## Disclosure Controls

The table generator implements:

- a configurable minimum cell size;
- primary suppression for small nonzero cells;
- an additional within-row suppression when exactly one group cell is suppressed;
- group-level suppression when denominators are too small;
- bounded groups and rows;
- omission of raw values and identifiers.

The default threshold is a conservative operational setting, not a universal rule. The helper does not model row/column dependencies, overlapping groups, or prior releases, so its within-row suppression does not guarantee protection from reconstruction. All supplied counts must remain internally consistent even if a group is suppressed. Validation errors prevent table export. CSV labels and summaries are escaped as text for spreadsheet use. It does not address all differencing, linkage, longitudinal, geographic, genomic, or rare-combination risks. Follow an approved disclosure policy and privacy review.

## Interpretation Template

Use:

> In this aggregate [design] evaluation, [effect/summary] was estimated as [value and interval] for [defined outcome and horizon]. The analysis is [prespecified/exploratory] and is limited by [bias, missingness, precision, transportability]. It does not establish causality, clinical utility, or an action for any person.

## Reporting

- STROBE for observational design.
- RECORD for routinely collected data.
- REMARK for tumor prognostic-marker studies.
- TRIPOD+AI for prediction-model development/evaluation.
- Appropriate causal-inference and target-trial reporting when making causal claims.

See `study_reporting.md` and `privacy_and_disclosure.md`.
rea-changelog-updatemorluto/reaPrepare or rewrite REA release changelogs and GitHub release notes from pinned Git history, with verified contributor thanks and Release Please synchronization.Stars: 472kUpdated Claude CodeCodexVerifiedInstall
academy-guideanthropics/skillsStop and check this skill before finishing any reply to a question about how to use Claude or a Claude product — it recommends matching courses, tutorials, and use cases from Claude Academy (academy.claude.com), Anthropic's learning hub. Trigger on: "how do I", "how can I", "getting started with", "what can Claude do", "teach me", "learn to use"; questions about artifacts, projects, skills, plugins, connectors, MCP; requests about rolling Claude out to a team, class, or organization; and any ask for training materials, onboarding content, or learning resources. Use it when the user is learning how to use a feature or product — not when they are mid-task and just want the task done. This skill composes with other skills: after consulting product documentation to answer how a Claude feature works, also check here for a matching course or tutorial — a docs-grounded answer and an Academy recommendation belong together. Only recommend on a strong match; never invent Academy content.Stars: 198kUpdated Claude CodeCodexVerifiedInstall
claude-apianthropics/skillsReference for the Claude API / Anthropic SDK — model ids, pricing, params, streaming, tool use, MCP, agents, caching, token counting, model migration. TRIGGER — read BEFORE opening the target file; don't skip because it "looks like a one-liner" — whenever: the prompt names Claude/Anthropic in any form (Claude, Anthropic, Fable, Opus, Sonnet, Haiku, `anthropic`, `@anthropic-ai`, `claude-*`, `us.anthropic.*`, `[1m]`); the user asks about an LLM (pricing/model choice/limits/caching) — never answer from memory; OR the task is LLM-shaped with provider unstated (agent/MCP/tool-definition/multi-agent/RAG/LLM-judge/computer-use; generate/summarize/extract/classify/rewrite/converse over NL; debugging refusals/cutoffs/streaming/tool-calls/tokens). SKIP only when another provider is being worked on (overrides all triggers): OpenAI/GPT/Gemini/Llama/Mistral/Cohere/Ollama named in the query; OR `grep -rE 'openai|langchain_openai|google.generativeai|genai|mistralai|cohere|ollama'` over the project hits (run this grep FIRST if no provider named — don't Read the file).Stars: 198kUpdated Claude CodeCodexUnverifiedInstall
doc-coauthoringanthropics/skillsGuide users through a structured workflow for co-authoring documentation. Use when user wants to write documentation, proposals, technical specs, decision docs, or similar structured content. This workflow helps users efficiently transfer context, refine content through iteration, and verify the doc works for readers. Trigger when user mentions writing docs, creating proposals, drafting specs, or similar documentation tasks.Stars: 198kUpdated Claude CodeCodexVerifiedInstall